Inactive Instrument

ENTST BIO Stock Other OTC

Investment Holding Companies

End-of-day quote Other OTC Other stock markets
- ^USD	-

2020	Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019	CI
2019	Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019	CI

Entest Group, Inc., formerly Entest Biomedical, Inc., is engaged in the business combination with an unidentified company. The Company has not entered into any definitive agreement with any party, nor have there been any specific discussions with any potential business combination candidate regarding business opportunities for the Company.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+89.66%	4.54B
SCREAMING EAGLE ACQUISITION CORP.	+1.60%	1.01B
CHURCHILL CAPITAL CORP VII	+1.90%	980M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+23.88%	809M
ARES ACQUISITION CORPORATION II	+1.82%	664M
E7 GROUP	+0.90%	612M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+19.98%	546M

Shell Companies

Sales 2018	-	Sales 2019	-	Capitalization	983K
Net income 2018	-1M	Net income 2019	-	EV / Sales 2018	-
Net Debt 2018	19.4K	Net Debt 2019	21.2K	EV / Sales 2019	-
P/E ratio 2018	-0.92 x	P/E ratio 2019	12.6 x	Employees	-
Yield 2018 *	-	Yield 2019	-	Free-Float	98.54%

Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019	20-01-21	CI
Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019	19-12-20	CI
Entest Group, Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2019	19-07-15	CI
Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2018	19-01-22	CI
Entest Group, Inc. Announces Management Changes	18-12-03	CI
Peiwen Yu completed the acquisition of 48.3% stake in Entest Group, Inc. from Regen BioPharma, Inc., Bostonia Partners, Inc, Dunhill Ross Partners, Inc., Bio-Technology Partners Business Trust, David Koos and Sherman Family Trust.	18-11-26	CI
Peiwen Yu entered into an agreement to acquire 48.3% stake in Entest Group, Inc. from Regen BioPharma, Inc., Bostonia Partners, Inc, Dunhill Ross Partners, Inc., Bio-Technology Partners Business Trust, David Koos and Sherman Family Trust for $0.33 million.	18-11-19	CI
ENTB will Change its Name to ETNI	18-02-14	CI
Entest Group, Inc. Auditor Raises 'Going Concern' Doubt	15-11-26	CI
Entest Biomedical, Inc. will Change its Ticker to ENTB from ENTB.D	15-08-21	CI
Entest Biomedical, Inc. will Change its Ticker to ENTBD from ENTB	15-07-27	CI
Christine Ichim Joins Entest BioMedical Inc. as Director of Research	14-07-16	CI
Entest Biomedical Mulls Acquisitions	13-03-06	CI
Entest Biomedical, Inc. Announces the Research Study Conducted on ImenVax(TM)	12-09-06	CI
Entest Biomedical, Inc. Restates Earnings Results for the Quarter Ended May 31, 2012	12-07-23	CI

ENTEST : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	20-01-21	AQ
ENTEST GROUP, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	20-01-07	AQ
ENTEST : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	19-12-20	AQ
Entest Group, Inc. : Declares Property Dividend of 3,000,000 Common Shares of Zander Therapeutics Inc.	18-05-10	PR
Entest Biomedical : Zander Therapeutics, Inc. Announces Appointment of Dr. Robin Beat Gasser to Scientific Advisory Board	17-09-13	PR

ENTST BIO Stock Other OTC

Equities

Investment Holding Companies

Financials (USD)

Latest news about ENTST BIO

Press releases ENTST BIO

Managers and Directors - ENTST BIO

Company Profile

Sector Shell Companies